KCM
SCMP

Kennedy Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Kennedy Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-353,528
Closed -$6.35M – 799
2017
Q4 		$6.35M Buy
+353,528
New +$4.35M 0.11% 330

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Kennedy Capital Management's SCMP Position: Q1 2018 in Review

Kennedy Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 353,528 shares — an estimated $6.35M sold.

Kennedy Capital Management first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $6.35M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Kennedy Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Kennedy Capital Management sold 353,528 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $6.35M.
  • Kennedy Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Kennedy Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $6.35M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Kennedy Capital Management's 13F filing for Q1 2018, filed 14 May 2018.